These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2721162)

  • 1. The global extrapolation of numerical methods for computing concentration profiles in percutaneous drug absorption.
    Twizell EH
    Comput Biol Med; 1989; 19(3):163-71. PubMed ID: 2721162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lag time in the dual sorption model for percutaneous absorption with finite skin-receptor boundary clearance.
    Twizell EH; Kubota K
    Math Biosci; 1994 Sep; 123(1):1-23. PubMed ID: 7949743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-dimensional mathematical model of percutaneous drug absorption.
    George K; Kubota K; Twizell EH
    Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonlinear numerical model of percutaneous drug absorption.
    Kubota K; Twizell EH
    Math Biosci; 1992 Mar; 108(2):157-78. PubMed ID: 1547360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
    Simon L; Loney NW
    Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential algorithm for the non-linear dual-sorption model of percutaneous drug absorption.
    Gumel AB; Kubota K; Twizell EH
    Math Biosci; 1998 Aug; 152(1):87-103. PubMed ID: 9727298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On mathematical modeling of dermal and transdermal drug delivery.
    Manitz R; Lucht W; Strehmel K; Weiner R; Neubert R
    J Pharm Sci; 1998 Jul; 87(7):873-9. PubMed ID: 9649357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The percutaneous absorption of propranolol and prediction of the plasma concentration.
    Ogiso T; Ito Y; Iwaki M; Shintani A
    J Pharmacobiodyn; 1988 May; 11(5):349-55. PubMed ID: 3171877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bivariate Chebyshev spectral collocation quasilinearization method for nonlinear evolution parabolic equations.
    Motsa SS; Magagula VM; Sibanda P
    ScientificWorldJournal; 2014; 2014():581987. PubMed ID: 25254252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration.
    Anissimov YG; Roberts MS
    J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous pharmacokinetics of topically applied maxacalcitol ointment and lotion.
    Umemura K; Ikeda Y; Kondo K; Hirata K; Amagishi H; Ishihama Y; Tokura Y
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):289-94. PubMed ID: 18541125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel ointment of verapamil for percutaneous absorption.
    Sekine T; Machida Y; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):245-52. PubMed ID: 3509338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model.
    Heisig M; Lieckfeldt R; Wittum G; Mazurkevich G; Lee G
    Pharm Res; 1996 Mar; 13(3):421-6. PubMed ID: 8692735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous absorption of indomethacin from ointment following repeated administration in rabbits.
    Tsai YH; Huang LC; Naito SI
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Apr; 1(4):234-9. PubMed ID: 3871034
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of d-limonene on the amounts of ethanol and indomethacin penetrated from aqueous gel ointments to rat skin.
    Kikuchi K; Takayama K; Nagai T
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3108-9. PubMed ID: 1477929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical approach to predicting the percutaneous absorption enhancing effect of sodium lauryl sulphate.
    Borrás-Blasco J; Díez-Sales O; López A; Herráez-Domínguez M
    Int J Pharm; 2004 Jan; 269(1):121-9. PubMed ID: 14698583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polysorbates on percutaneous absorption of indomethacin from ointment in rabbits.
    Tsai YH; Yang MY; Naito S
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Aug; 2(8):522-31. PubMed ID: 3482701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.